South Korean AI software developer Lunit has completed a $193 million acquisition of breast and lung imaging software firm Volpara Health Technologies.
The deal, announced late last year, is expected to boost Lunit’s capabilities in AI-driven cancer diagnostics and brings the company access to Volpara’s installed base in the U.S. market. In addition, Lunit will integrate Volpara’s breast density and screening workflow platform with its AI-powered solutions for breast cancer detection.
